3 Australian Stocks Trading Below Cash Flow Value

With inflation paths, central bank decisions and consumer demand sending mixed signals across major economies, many investors are looking for clearer anchors in company fundamentals. Cash generation can be one of those anchors. The Undervalued Stocks Based On Cash Flows screener focuses on companies where SWS DCF valuation suggests the market price sits below estimated fair value, based on cash flow potential rather than short term headlines. This article highlights 3 of the best stocks from that screener and explains why their cash flow profiles may appeal to value oriented investors who want fundamentals to drive their watchlist.

Mesoblast (ASX:MSB)

Overview: Mesoblast is a Melbourne based biotech company that develops regenerative cell therapies using mesenchymal lineage cells to treat severe inflammatory, cardiovascular and chronic pain conditions, such as graft versus host disease, inflammatory bowel disease, chronic low back pain and heart failure.

Operations: Mesoblast generates around US$65.4 million from developing its mesenchymal cell technology platform for commercialization.

Market Cap: A$2.68b

Mesoblast gives you exposure to a late stage cell therapy platform with an FDA approved product, Ryoncil, already on the market and several Phase III programs in large indications such as chronic low back pain and heart failure. Recent updates in 2026 show active progress on pivotal trials and regulatory filings, supported by additional funding that extends its cash runway. At the same time, Mesoblast is still loss making, relies on higher risk external funding and depends heavily on successful trial outcomes and stable reimbursement, so execution risk is material. The relationship between current pricing and cash flow based estimates will depend on how these factors evolve.

Mesoblast’s late stage pipeline and fresh funding have shifted attention toward what its cash flows might look like if key programs progress. Review the DCF valuation analysis for Mesoblast to see how those scenarios could reshape the story.

Lynas Rare Earths (ASX:LYC)

Overview: Lynas Rare Earths is a Perth headquartered miner and processor that supplies rare earth elements used in electric vehicles, wind turbines and other high tech applications, with operations built around its Mt Weld mine in Western Australia and processing plants in Australia and Malaysia.

Operations: Lynas Rare Earths generates about A$715.9 million in revenue from its rare earth operations.

Market Cap: A$14.78b

Lynas Rare Earths attracts interest because it offers pure exposure to rare earths used in electrification. At the same time, you need to weigh that potential against concentrated exposure to a single commodity chain, reliance on external borrowing and ongoing regulatory scrutiny in Malaysia, including recent parliamentary questions around its Pentagon supply deal. New downstream projects such as the JS Link magnet collaboration could deepen customer relationships and margins if execution goes to plan, but they also lift capital and policy risk. The real question is how you balance that growth story against the pricing and funding risks that the market may be underpricing today.

Lynas Rare Earths sits at the heart of the EV and wind supply chain, yet its concentrated exposure and policy questions could be masking the real story. Scan the full analysis report for Lynas Rare Earths to see what might be missing.

WiseTech Global (ASX:WTC)

Overview: WiseTech Global develops and sells software that helps logistics providers manage the movement and storage of goods and data across global supply chains, covering forwarding, customs, transport, warehousing and enterprise functions. Its CargoWise platform and related tools are used by logistics businesses in the Americas, Asia Pacific, Europe, the Middle East and Africa.

Operations: WiseTech Global currently generates revenue across the Americas (US$450.7 million), Asia Pacific (US$254.8 million) and Europe, the Middle East and Africa (US$364.2 million).

Market Cap: A$11.57b

WiseTech Global is attracting fresh interest because it sits at the centre of supply chain digitization, with unified, AI driven SaaS tools and the E2open acquisition widening its reach across the full logistics chain. Earnings and revenue are both forecast to grow at double digit rates. However, recent earnings pressure, a one off loss and an underperforming share price show sentiment is still cautious. Debt funding for E2open and a complex integration plan add real execution risk. In addition, recent governance changes, including a new independent chair in July 2026, signal a reset in oversight. For investors, the tension between higher growth expectations, richer valuation multiples and these operational risks is where the real opportunity or downside sits.

WiseTech Global’s growth story and the E2open scale-up could be masking the real hinge point for future cash flows. Get the full picture in the analyst forecasts for WiseTech Global that also flags one risk most investors overlook.

The three stocks in this article are only a starting point. The full Undervalued Stocks Based On Cash Flows screener surfaces 37 more companies that pair discounted prices with cash flow stories that could be just as compelling as Mesoblast, Lynas Rare Earths and WiseTech Global. Identify your own highest conviction ideas by using Simply Wall St to filter the Undervalued Stocks Based On Cash Flows screener for the specific catalysts and narratives that matter most to you.

Take Control of Your Investment Journey

If Mesoblast or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Fresh Alternatives For Your Next Move

New ideas can move from quiet to breakout fast. Use fresh screeners to spot momentum while it matters, before prices get caught flying or dropping. Get in early.

• Target sturdier income streams by reviewing 5 dividend fortresses that aim to keep yields flying while weaker payouts are still dropping off the radar.
• Hunt for resilient growth by checking the 9 resilient stocks with low risk scores that highlight companies where balance sheets and risk scores are built to handle shifting momentum.
• Ride the next digital infrastructure wave by scanning 56 AI infrastructure stocks curated for businesses building the backbone behind AI capacity and data center expansion.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com